Search - tctmd.com

Displaying 761 - 780 of 1167

Sort: Relevancy | Date

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Industry News

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

June 23, 2015

News Industry News

Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve

June 17, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

News Industry News

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

June 03, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Daily News

Endurant Stent Graft Appears Safe, Effective in AAA Patients With Challenging Anatomy

May 28, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Conference News EuroPCR 2015

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Yael L. Maxwell

May 21, 2015

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Conference News EuroPCR 2015

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

Yael L. Maxwell

May 19, 2015

News Industry News

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

May 19, 2015

News Daily News

FRANCE 2: Prior CABG Does Not Influence Mortality After TAVR

Todd Neale

May 18, 2015

News Daily News

Melody Valve Yields Good Long-term Results, Especially With Pre-Stenting

Todd Neale

May 14, 2015

News Industry News

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

May 12, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

Sarcopenia, Pulmonary Abnormalities Useful Risk Markers in Aortic Valve Replacement

April 30, 2015

News Daily News

分期 PCI 和 TAVR 之间的时间对短期结局有极轻微影响

Yael L. Maxwell

April 29, 2015

News Daily News

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Yael L. Maxwell

April 29, 2015

Advertisement

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve

LV Flow After TAVR Predicts Late Mortality

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Endurant Stent Graft Appears Safe, Effective in AAA Patients With Challenging Anatomy

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

FRANCE 2: Prior CABG Does Not Influence Mortality After TAVR

Melody Valve Yields Good Long-term Results, Especially With Pre-Stenting

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

Sarcopenia, Pulmonary Abnormalities Useful Risk Markers in Aortic Valve Replacement

分期 PCI 和 TAVR 之间的时间对短期结局有极轻微影响

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content